Famotidine Recalled
November 17, 2025
On Nov. 6, 2025, Fresenius Kabi initiated a voluntary nationwide recall of three lots of famotidine injection, USP, 20mg per 2mL (10mg per mL).
Express Scripts® Pharmacy Benefit Services
After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available. Please visit the U.S. Food and Drug Administration (FDA) website for the most up-to-date information on drug safety and recalls.
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.